JD Supra: Mergers

MARCH 29, 2024

On February 22, 2024, the Minnesota legislature introduced a bill (SF-4392 and companion bill HR-4206) which seeks to curb the control and acquisition over certain healthcare providers by private equity companies and real estate investment trusts (REITs). By: Lathrop GPM

Healthcare 196

Healthcare Investment Private Equity Equities 196

JD Supra: Mergers

OCTOBER 11, 2024

In a recent episode of the Heart of Healthcare podcast, co-hosts Michael T. Esquivel and Halle Tecco, sat down with Federal Trade Commission (FTC) Chair Lina Khan, who offered her perspective on the intersection of antitrust enforcement and the healthcare industry. By: Fenwick & West LLP

Healthcare 172

Healthcare Trading 172

JD Supra: Mergers

JANUARY 24, 2025

The Act increases regulatory reporting obligations and oversight of healthcare transactions involving private equity sponsors, healthcare real estate investment trusts (REITs) and management services organizations (MSOs). Maura Healy signed An Act Enhancing the Market Review Process (the Act). By: McGuireWoods LLP

Healthcare 155

Healthcare Private Equity Investors Equities 155

JD Supra: Mergers

MAY 1, 2024

Companies should prepare for increased regulatory scrutiny into healthcare transactions and increased emphasis on compliance programs. We are tracking the inquiry and summarize here the. By: Latham & Watkins LLP

Healthcare 172

Healthcare Corporation Trading 172

JD Supra: Mergers

MARCH 15, 2024

From the West Coast Healthcare Desk is an ongoing series of Holland & Knight Healthcare Blog articles and alerts focused on healthcare industry developments and points of interest in the West Coast healthcare marketplace.

Healthcare 172

Healthcare Private Equity Equities 172

JD Supra: Mergers

JANUARY 10, 2024

Sustainability of our healthcare system was an interesting topic at Day 2 of the 42nd Annual J.P. Morgan Healthcare Conference. Paul Markovich, CEO of Blue Shield of California, expressed the concern that “[T]he status quo is an existential threat to our healthcare system.”

Healthcare 196

Healthcare IT 196

JD Supra: Mergers

JUNE 18, 2024

The following states have proposed, but not passed, additional state healthcare transaction notification laws. By: Goodwin

Healthcare 167

Healthcare 167

JD Supra: Mergers

SEPTEMBER 20, 2024

In the second quarter, federal and state antitrust enforcers continued their intense scrutiny of consolidation in the healthcare market by implementing new initiatives and laws designed to gather additional information regarding transactions and conduct in the space. By: Goodwin

Healthcare 177

Healthcare 177

JD Supra: Mergers

JULY 9, 2024

Exiting a business, whether you are a serial entrepreneur looking to move on to the next project or a healthcare provider like a physician or therapist who has nurtured your practice for decades, can be difficult. After all, corporate transactions are complex affairs that often hang on small details.

Healthcare 182

Healthcare Corporation Business 182

JD Supra: Mergers

AUGUST 2, 2024

Investment in the healthcare industry requires careful consideration, as it involves numerous distinct areas of the law. Venable's Private Equity Investment in Healthcare webinar series explores the unique issues and timely developments that shape deals within the industry. By: Venable LLP

Private Equity 167

Private Equity Healthcare Equities Investment 167

JD Supra: Mergers

JUNE 3, 2024

Rapid digitalization in the health industry is set to drive M&A across the region - Digitalization is reshaping the global healthcare industry as demand for personalized, more accessible care fuels innovative market solutions. This fresh prioritization prompted a surge of investment and innovation, with the value of the global digital.

Healthcare 172

Healthcare M&A Management Investment 172

JD Supra: Mergers

MAY 9, 2024

Knox Lane has announced the acquisition of All Star Healthcare Solutions. By: McGuireWoods LLP

Healthcare 149

Healthcare Private Equity Hospitality Equities 149

JD Supra: Mergers

AUGUST 1, 2024

At the end of last year, Holland & Knight predicted that "the current enforcement environment will continue into 2024 and will focus heavily on the healthcare industry, along with private equity transactions or 'roll-ups.' 15, 2023.)

Private Equity 167

Private Equity Healthcare Equities 167

JD Supra: Mergers

JUNE 18, 2024

healthcare space has grown dramatically in recent years, in large part based on the significant increase in private investment. This has not gone unnoticed, and U.S.

Healthcare 155

Healthcare Investment 155

JD Supra: Mergers

FEBRUARY 28, 2024

In the second week of January, Goodwin and KPMG convened innovators, practitioners, regulators, and others for our annual symposium on the future of life sciences and healthcare. Morgan Healthcare Conference in San Francisco. This marked the fifth year that Goodwin co-hosted the symposium, which takes place during the annual J.P.

Healthcare 200

Healthcare IPO M&A 200

JD Supra: Mergers

OCTOBER 21, 2024

In the healthcare mergers and acquisitions (M&A) market, while deal volumes varied across different sectors, by and large the sure and steady pace of deal volume in Q2 continued into Q3.

Healthcare 167

Healthcare Mergers and Acquisitions M&A Mergers 167

JD Supra: Mergers

SEPTEMBER 17, 2024

Investment in the healthcare industry requires careful consideration, as it involves numerous distinct areas of the law. Venable's Private Equity Investment in Healthcare webinar series explores the unique issues and timely developments that shape deals within the industry. By: Venable LLP

Healthcare 177

Healthcare Private Equity Equities Investment 177

JD Supra: Mergers

FEBRUARY 26, 2025

healthcare sector faces a complex and evolving regulatory and legislative landscape. Private equity (PE) investment in the U.S. Both federal and state authorities are intensifying scrutiny of PE investment, driven by concerns about market consolidation, quality of care, corporate profiteering and lack of financial transparency. By: Benesch

Private Equity 182

Private Equity Healthcare Equities Investment 182

JD Supra: Mergers

JULY 2, 2024

Triton Pacific Healthcare Partners has announced the closing of its sale of BioMatrix Specialty Infusion Pharmacy to Frazier Healthcare Partners. BioMatrix, founded in 2001 and based in Plantation, Florida, is a provider of specialty infusion services in the United States. By: McGuireWoods LLP

Healthcare 149

Healthcare Private Equity Equities Sale 149

JD Supra: Mergers

MAY 21, 2024

Earlier this year, Indiana joined a growing number of states by enacting a new notification requirement for certain healthcare transactions.

Healthcare 187

Healthcare Private Equity Equities Investors 187

JD Supra: Mergers

MAY 21, 2024

BRight Minds in Healthcare Delivery invites industry leaders to discuss the latest trends and hot topics in healthcare strategy, delivery, and innovation. Listen in as industry experts, thought leaders, and innovators consider how to disrupt the way that millions of Americans receive healthcare. By: Blank Rome LLP

Healthcare 149

Healthcare Investment 149

JD Supra: Mergers

NOVEMBER 10, 2023

After steadying during Q2, it appears the overall volume of deals in the healthcare industry declined in Q3 compared with Q2, and year-to-date 2023 is still down from last year.

Healthcare 182

Healthcare IT 182

JD Supra: Mergers

OCTOBER 3, 2024

3129), which would have required private equity funds and hedge funds to obtain consent before entering into certain healthcare transactions. 3129 into law, certain investments in a healthcare facility, provider, or provider. Gavin Newsom vetoed California Assembly Bill 3129 (A.B. The closely monitored legislative effort behind A.B.

Healthcare 161

Healthcare Investment Private Equity Consulting 161

JD Supra: Mergers

JANUARY 17, 2025

Private equity sponsors and their healthcare portfolio companies are expected to ride the tailwind of an M&A rebound. Long-term capital gains tax rates will likely remain unchanged, or possibly drop. As a result, sellers may be incentivized to explore market opportunities without requiring investors to gross-up purchase multiple premiums.

Healthcare 172

Healthcare Private Equity Portfolio M&A 172

JD Supra: Mergers

JUNE 18, 2024

The California Office of Health Care Affordability and the California Attorney General both require entities to provide notification about certain healthcare transactions. We provide details about both sets of requirements below. By: Goodwin

Healthcare 161

Healthcare 161

JD Supra: Mergers

AUGUST 29, 2024

Driven by a growing wave of enforcer skepticism toward further healthcare consolidation, some state legislatures have begun to propose “mini-HSR” laws explicitly targeting healthcare transactions involving private equity firms or sponsors. By: Morgan Lewis

Private Equity 167

Private Equity Healthcare Equities 167

JD Supra: Mergers

DECEMBER 24, 2024

Investment in the healthcare industry requires careful consideration, as it involves numerous distinct areas of the law. Venable's Private Equity Investment in Healthcare webinar series explores the unique issues and timely developments that shape deals within the industry. By: Venable LLP

Healthcare 167

Healthcare Private Equity Equities Investment 167

JD Supra: Mergers

MARCH 12, 2024

2023 saw a significant uptick in antitrust scrutiny and enforcement, particularly in the healthcare space.

Healthcare 187

Healthcare Private Equity Mergers Equities 187

JD Supra: Mergers

JUNE 18, 2024

Key Takeaways -.Requires

Healthcare 167

Healthcare Mergers and Acquisitions Mergers Acquisitions 167

JD Supra: Mergers

MARCH 28, 2024

While private equity (PE) investments in healthcare have long been subject to scrutiny, as PE investment in healthcare has grown sizably over the last decade, so too has the concern from federal and state regulatory bodies surrounding this type of investment.

Healthcare 167

Healthcare Investment Private Equity Equities 167

JD Supra: Mergers

OCTOBER 14, 2024

2024 has been an eventful year for federal and state antitrust enforcement in healthcare with many in the industry wondering where do we go from here in 2025.

Healthcare 177

Healthcare 177

JD Supra: Mergers

OCTOBER 9, 2023

Growing state-level oversight of M&A and other strategic transactions for healthcare provider businesses will impact growth strategies across major markets.

Healthcare 172

Healthcare Collaboration M&A Investors 172

JD Supra: Mergers

OCTOBER 11, 2024

State legislatures across the country are beginning to consider and debate the pros and cons of passing laws aimed at regulating private equity’s role in the healthcare industry. According to an article in the Wall Street Journal on April 18, 2024, 12 states have already passed legislation regulating private equity involvement in healthcare.

Private Equity 172

Private Equity Healthcare Equities 172

JD Supra: Mergers

JANUARY 7, 2025

As the healthcare industry heads into 2025, deals attorneys are optimistic as they look to falling interest rates and a potentially more business-friendly administration set to enter the White House. Originally published in Law360 - January 1, 2025. By: Latham & Watkins LLP

Healthcare 172

Healthcare Business 172

JD Supra: Mergers

AUGUST 15, 2024

healthcare industry has weathered the storm over the past couple of years, we may be reaching calmer waters in the coming months. With that backdrop, navigating the healthcare M&A landscape continues to be increasingly challenging, especially with an ever-evolving regulatory landscape. Although the U.S. Dry powder held by U.S.

Private Equity 172

Private Equity Healthcare Equities M&A 172

JD Supra: Mergers

JANUARY 15, 2025

5159), An Act Enhancing the Market Review Process (the Act), which, among other things, broadens the scope of the states existing healthcare transaction notification and review regime. On January 8, 2025, Massachusetts Governor Maura Healey signed House Bill 5159 (H.5159), By: Goodwin

Healthcare 161

Healthcare Private Equity Equities Investment 161